Stargate CEOs cite project’s promise of enabling cancer vaccines, though Musk joins critics in questioning partners’ ...

Big business has an inside track in the second Trump presidency, and people with a stake in those businesses have reason to ...

We recently published a list of These 10 Firms Were Thursday’s Top Performers. In this article, we are going to take a look ...

H.C. Wainwright analyst Edward White reiterated a Buy rating on Valneva (VALN – Research Report) today and set a price target of $18.00.Invest ...

The pharmaceutical industry could generate more than $1.2 trillion in global sales in 2025, according to Statista. The cancer segment alone is expected to generate $208 billion in sales this year.

SINGAPORE: The updated JN.1 Novavax/Nuvaxovid COVID-19 vaccine will be offered under the national vaccination programme at ...

In 2024, companies in the broader market that paid dividends returned around 35% of their net income and 45% of their free ...

The stock has spent the past few years in the shadow of a COVID-19 boost, but it's time investors see the light.

Netflix earnings after the bell drive focus in tech stocks. Dow and S&P climb as optimism over trade policy fuels market ...

"Today’s court decision will only grant Ursula von der Leyen a temporary respite from trial," Belgian lobbyist Frederic Baldan stressed ...

Shares of Trump Media & Technology Group ( DJT ), which owns the Truth Social platform, were recently down 10% at about $36. They’ve mostly fallen since touching January highs above $40 and ...

RNA vaccine developer Moderna (MRNA) is climbing nearly 5% in early trading today after it was awarded about $590 million by ...